For comments, suggestions
Created with Raphaël 2.1.0 15.10.2016 Filing date 09.05.2018 Validation fee payment 31.10.2018 (A1) Patent application published 09.01.2026 Can request protection in MD until

Patent not validated (the request for validation was not submitted on time)


(210)Number of the EPO application16788877
(220)Filing date of the EPO application2016.10.15
(80)EPO patent specification publication (B)EPB nr. 28/2025, 2025.07.09
(110)EPO patent number3362049
(21)Number of the applicatione 2018 0815
(71)Name(s) of applicant(s), code of the countryIpsen Biopharm Ltd., GB;
(72)Name(s) of inventor(s), code of the countryDRUMMOND Daryl C., US;
KIRPOTIN Dmitri B., US;
HAYES Mark Eamon, US;
NOBLE Charles, US;
KESPER Kevin, US;
AWAD Antoine M., US;
MOORE Douglas J., US;
O'BRIEN Andrew J., US;
(73)Name(s) of owner(s), code of the countryIpsen Biopharm Ltd., GB;
(54)Title of the inventionSTABILIZING CAMPTOTHECIN PHARMACEUTICAL COMPOSITIONS
(13)Kind-of-document code A1
(51)International Patent Classification A61K 9/127 (2025.01.01); A61K 31/4745 (2006.01.01); A61P 35/00 (2006.01.01)
(52)Cooperative Patent Classification A61K 9/1271 (EP); A61K 9/1277 (EP); A61K 31/4745 (EP); A61P 35/00 (EP); Y10S 977/773 (EP); Y10S 977/906 (EP); Y10S 977/907 (EP)
(19)CountryGB
(41)Date of publication of the application2018.10.31
(30)Priority201562242873 P, 2015.10.16, US; 201562242835 P, 2015.10.16, US; 201562244082 P, 2015.10.20, US; 201562244061 P, 2015.10.20, US
(86)International applicationPCT/US2016/057247, 2016.10.15
(87)International publicationWO 2017/066726, 2017.04.20
Up
/Inventions/details/3362049